Company Filing History:
Years Active: 2021-2025
Title: Alan Russell: Innovator in Pharmaceutical Compounds
Introduction
Alan Russell is a prominent inventor based in Boulder, CO (US), known for his significant contributions to the field of pharmaceutical compounds. With a total of 9 patents, he has made strides in developing innovative treatments for various medical conditions.
Latest Patents
Among his latest patents, Russell has developed quinolinone amide compounds and their uses. This patent focuses on substituted quinolinone amide compounds or salts that may be utilized to treat or prevent cardiac disease in individuals in need. Another notable patent involves pyridazinone compounds, which are designed for the treatment of neuromuscular diseases, such as Duchenne Muscular Dystrophy (DMD). These compounds are particularly useful in modulating inflammatory inhibitors like IL-1, IL-6, or TNF-α.
Career Highlights
Throughout his career, Alan Russell has worked with notable companies, including Edgewise Therapeutics, Inc. and Edgewise Therapeutics, Inc. His work has been instrumental in advancing pharmaceutical research and development.
Collaborations
Russell has collaborated with esteemed colleagues, including Kevin W. Hunt and Kevin Koch, contributing to the innovative environment in which he operates.
Conclusion
Alan Russell's work in developing pharmaceutical compounds showcases his dedication to improving healthcare through innovation. His patents reflect a commitment to addressing critical medical challenges, particularly in cardiac and neuromuscular diseases.